Stay Vigilant When Prescribing Fentanyl

March 2021

You’ll see more focus on safe use of transdermal and transmucosal fentanyl products.

Issues continue to crop up with fentanyl patches.

Plus there are now updated Risk Evaluation and Mitigation Strategies (REMS) requirements for transmucosal immediate-release fentanyl (TIRF) products (Actiq, Fentora, etc)...partly to ensure they’re only used in opioid-tolerant patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

COVID-19 Share Facts About the New Viral Vector COVID-19 Vaccine
Immunizations Reduce Risk of Injury and Manage Pain From IM Vaccinations
Asthma Weigh Pros and Cons of SMART for Moderate to Severe Asthma
Headache Start Treatment ASAP for Cluster Headaches
Opioids Stay Vigilant When Prescribing Fentanyl
IBS Sort Out Meds for Irritable Bowel Syndrome
Prediabetes Focus on Lifestyle Changes to Help Tackle Prediabetes
Overactive Bladder Emphasize Nondrug Measures for Overactive Bladder...Not Meds
HIV & AIDS Watch for Cabenuva, a New Monthly Injectable for HIV
COVID-19 Guide Use of Tocilizumab for COVID-19 Based on New Data
Surgery Focus on Safe Use of Local Anesthetics for Post-Op Pain
Pediatrics Assess Best Options for Neonatal Opioid Withdrawal Protocols

Stay Vigilant When Prescribing Fentanyl

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents